[Federal Register Volume 64, Number 165 (Thursday, August 26, 1999)]
[Notices]
[Page 46686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22098]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Workshop on Bacterial Contamination of Platelets; Public Workshop
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
workshop entitled ``Bacterial Contamination of Platelets.'' The
objectives of the public workshop are to obtain current information on
bacterial contamination of platelets and to encourage future research
and development efforts to minimize the risk of transfusion reactions.
The public workshop will include an update on the epidemiology of
platelet contamination, advances in detection methodology of
contamination, and current strategies on bacterial inactivation and
contamination avoidance. Results from a U.S. study (the BaCon Study)
and similar European studies on microbial contamination will be
presented.
Date and Time: The public workshop will be held on Friday,
September 24, 1999, from 8:15 a.m. to 5 p.m.
Location: The public workshop will be held at the National
Institutes of Health (NIH), NIH Clinical Center, Bldg. 10, Jack Masur
Auditorium, 9000 Rockville Pike, Bethesda, MD.
Contact: Joseph Wilczek, Center for Biologics Evaluation and
Research (CBER) (HFM-350), Food and Drug Administration, 1401 Rockville
Pike, Rockville, MD 20852-1448, 301-827-6129, FAX 301-827-2843.
Registration and Requests for Oral Presentations: Mail or fax
registration information (including name, title, firm name, address,
telephone, and fax number) to Joseph Wilczek (address above) by Friday,
September 10, 1999. Onsite registration will be done on a space-
available basis on the day of the public workshop, beginning at 7:30
a.m. There is no registration fee for the public workshop. Space is
limited, therefore, interested parties are encouraged to register
early.
If you need special accommodations due to a disability, please
contact Joseph Wilczek at least 7 days in advance.
A poster session will be set up for the public workshop. All
participants are encouraged to present their study results in poster
format. A limited number of abstracts may be selected for oral
presentations. Send your abstracts and requests for oral presentations
to Chiang Syin, Division of Transfusion Transmitted Diseases (HFM-320),
CBER, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827-6465, FAX
301-594-6989, or e-mail syin@cber.fda.gov'' by Friday, September 10,
1999.
Transcripts: Transcripts of the meeting may be requested in writing
from the Freedom of Information Office (HFI-35), Food and Drug
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857,
approximately 15 working days after the meeting at a cost of 10 cents
per page. The meeting transcript will also be available on CBER's
website at ``http://www.fda.gov/cber/minutes/workshop-min.htm''.
Dated: August 17, 1999.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning and Legislation.
[FR Doc. 99-22098 Filed 8-25-99; 8:45 am]
BILLING CODE 4160-01-F
